Share on StockTwits

Medidata Solutions (NASDAQ: MDSO) was the recipient of a ratings changes during the seven days:

  • Medidata Solutions had its “buy” rating reaffirmed by analysts at Citigroup Inc.. They now have a $53.00 price target on the stock.
  • Medidata Solutions had its price target lowered by analysts at Deutsche Bank from $67.00 to $57.00. They now have a “buy” rating on the stock.
  • Medidata Solutions had its “buy” rating reaffirmed by analysts at Jefferies Group. They now have a $50.00 price target on the stock, down previously from $72.50.
  • Medidata Solutions had its “buy” rating reaffirmed by analysts at SunTrust. They now have a $50.00 price target on the stock.
  • Medidata Solutions was upgraded by analysts at B. Riley from a “neutral” rating to a “buy” rating. They now have a $49.00 price target on the stock.
  • Medidata Solutions had its price target lowered by analysts at Needham & Company LLC from $67.00 to $50.00. They now have a “buy” rating on the stock.
  • Medidata Solutions was upgraded by analysts at Riley & Co. from a “neutral” rating to a “buy” rating. They now have a $49.00 price target on the stock, down previously from $53.00.

Shares of Medidata Solutions Inc (NASDAQ:MDSO) opened at 43.93 on Thursday. Medidata Solutions Inc has a 1-year low of $26.57 and a 1-year high of $68.21. The stock’s 50-day moving average is $56.01 and its 200-day moving average is $57.36. The company has a market cap of $2.283 billion and a price-to-earnings ratio of 131.32.

Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.